Telix Gains FDA Approval for Pixclara in Glioma Imaging
MELBOURNE, Australia and INDIANAPOLIS, Ind. — September 14, 2026 Telix Pharmaceuticals announced that the U.S. Food and Drug Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
MELBOURNE, Australia and INDIANAPOLIS, Ind. — September 14, 2026 Telix Pharmaceuticals announced that the U.S. Food and Drug Administration...
Amsterdam, the Netherlands, September 3, 2026 Royal Philips has introduced the eV14-2v transvaginal transducer, a new single-transducer solution designed...
MELBOURNE, Australia and INDIANAPOLIS, September 2, 2026 Telix Pharmaceuticals Limited has completed enrollment of 350 patients in its Phase...
CHICAGO, August 31, 2026 GE HealthCare announced that its Photonova™ Spectra photon-counting computed tomography (PCCT) system has received CE...
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
Boston & Bedford, Massachusetts, August 3, 2026 Curium and Lantheus Holdings, Inc. have entered into a definitive merger agreement...
Boston, Massachusetts, August 3, 2026 Haemonetics Corporation has announced the publication of a major real-world clinical study providing additional...
AMSTERDAM, Netherlands, July 8, 2026 Philips announced the launch of Alturion, a next-generation AI-powered ultrasound system designed to improve...
VANCOUVER, British Columbia, July 6, 2026 Grey Matters Health Inc. announced the delivery of its first FDA-cleared CareMiBrain™ brain-dedicated...
NEW YORK, June 25, 2026 Aidoc announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
